CLARITAS: Phenotypic and Multi-Omic Readouts for Rare Cancer Combination Therapy
National Institutes of Health · United States
Time Left to Bid
Awarded
Basic information
- Reference number
- 75N91025C00043
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- CLARITAS: Phenotypic and Multi-Omic Readouts for Rare Cancer Combination Therapy
- Source
- USASpending (Federal)
- Source ID
- usa-75N91025C00043
Details
- Location
- United States
Summary
This is an awarded research contract with the National Institutes of Health for the CLARITAS project, which focuses on developing phenotypic and multi-omic readout technologies to inform combination therapy approaches for rare cancers. The project aims to integrate multiple data types (genomics, proteomics, etc.) to better understand cancer biology and optimize treatment strategies. The contract has been awarded to Radiant DX Inc.
Description
CLARITAS: PHENOTYPIC AND MULTI-OMIC READOUTS TO INFORM RARE CANCER COMBINATION THERAPY Awarded to: RADIANT DX INC. Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2025/08/27 12:00:00 AM UTC
- Closing date
- 2026/05/26 12:00:00 AM UTC
Estimated value
$300K USD
Classification
Normalized category